148 related articles for article (PubMed ID: 1971592)
1. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
McCaffrey PM; Riddell JG; Shanks RG
Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
[TBL] [Abstract][Full Text] [Related]
2. The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
McCaffrey PM; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1988 May; 11(5):543-51. PubMed ID: 2455840
[TBL] [Abstract][Full Text] [Related]
3. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Silke B; Hanratty CG; Riddell JG
J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
[TBL] [Abstract][Full Text] [Related]
4. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.
Vigholt-Sørensen E; Påby L; Halliday SE; Snow HM
Pharmacol Toxicol; 1991 Nov; 69(5):351-4. PubMed ID: 1687080
[TBL] [Abstract][Full Text] [Related]
6. Facilitation of norepinephrine release from cerebral cortex is mediated by beta 2-adrenergic receptors.
Murugaiah KD; O'Donnell JM
Life Sci; 1995; 57(20):PL327-32. PubMed ID: 7475928
[TBL] [Abstract][Full Text] [Related]
7. The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
Hadfield SE; Slee SJ; Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):78S-81S. PubMed ID: 2572262
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
9. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
10. The in vitro pharmacology of xamoterol (ICI 118,587).
Malta E; Mian MA; Raper C
Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the properties of prenalterol and corwin at beta 1- and beta 2-adrenoreceptors in vitro.
Gurden JM; Apperley GH; Drew GM
J Auton Pharmacol; 1989 Apr; 9(2):79-91. PubMed ID: 2565903
[TBL] [Abstract][Full Text] [Related]
12. Effect of xamoterol on peripheral blood vessels in healthy subjects.
Fitzgerald DE
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):70S-72S. PubMed ID: 2572259
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods.
Hanratty CG; Silke B; Riddell JG
Br J Clin Pharmacol; 1999 Feb; 47(2):157-66. PubMed ID: 10190650
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
15. Studies of the agonist and antagonist activity of cicloprolol in man.
McCaffrey PM; Burke M; Riddell JG; Shanks RG
Eur J Clin Pharmacol; 1988; 34(6):569-75. PubMed ID: 3169110
[TBL] [Abstract][Full Text] [Related]
16. The electrophysiological effects of intravenous xamoterol in man.
Bowes RJ; Gautam PC; Graham DR; Harley A
Eur J Clin Pharmacol; 1986; 29(6):731-4. PubMed ID: 2872057
[TBL] [Abstract][Full Text] [Related]
17. Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure.
Ollivier JP; Ricordei I; Bayon P; Popelard P; Moyse D; de Bourayne J; Dupont C; Droniou J
Eur Heart J; 1990 Apr; 11 Suppl A():59-60. PubMed ID: 1971594
[TBL] [Abstract][Full Text] [Related]
18. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.
Grove A; McFarlane LC; Lipworth BJ
Thorax; 1995 Feb; 50(2):134-8. PubMed ID: 7701450
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an atypical, or beta 3-adrenoceptor in ferret tracheal epithelium.
Webber SE; Stock MJ
Br J Pharmacol; 1992 Apr; 105(4):857-62. PubMed ID: 1354537
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
